The FDA approved the pill Nereus (tradipitant) as a new treatment for vomiting caused by motion sickness, with fewer side ...

The Food and Drug Administration has approved Nereus (tradipitant) for the prevention of vomiting induced by motion in adults.

Millions of Americans can now look forward to a better time traveling, with the US Food and Drug Administration (FDA) ...

Does motion sickness turn you into a green, spewing mess? For plenty of people, the answer is yes. Current remedies may or ...

Analysts raise price targets for Vanda Pharmaceuticals after FDA approved a motion sickness drug, citing growth potential.

Vanda Pharmaceuticals has received FDA approval for Nereus (tradipitant), an oral NK-1 receptor antagonist developed to prevent motion-induced vomiting. The approval makes Nereus the first new ...

Vanda also sells sleep disorder drug Hetlioz, which reached the market in 2014, and relapsing multiple sclerosis treatment Ponvory, which was approved in 2021. The FDA is scheduled on Jan. 7 to decide ...

There hasn’t been a new treatment for motion sickness approved by the Food and Drug Administration in 40 years, but D.C.-based Vanda Pharmaceuticals is advancing development of one that may eventually ...

The "Motion Sickness Treatment Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. The Motion Sickness Treatment Market has seen consistent growth, advancing from ...

Dublin, Dec. 18, 2025 (GLOBE NEWSWIRE) -- The "Motion Sickness Treatment Market - Global Forecast 2025-2032" has been added to ResearchAndMarkets.com's offering. The Motion Sickness Treatment Market ...

This informational guide, part of POPSUGAR's Condition Center, lays out the realities of this health concern: what it is, what it can look like, and strategies that medical experts say are proven to ...